
Neolen is an AI-powered drug repurposing and biomedical evidence platform built for translational researchers, pharma R&D, rare disease foundations, and biotech in-licensing teams. It leverages a biomedical knowledge graph (from 35M+ PubMed abstracts and scientific databases) to generate ranked hypotheses for new uses of existing drugs, and validates these hypotheses against real hospital data within days. Its two-part engine combines discovery from public data with in-context evidence gathering behind PHI boundaries, providing explainable, citation-backed outputs for rapid hypothesis validation and cohort-based analysis.
Visit Neolen's official website for product details and getting started.
Comprehensive guides and API documentation for using Neolen's platform effectively.
Insights and updates on drug repurposing and the latest advancements in biomedical research.
Details on subscription plans and pricing options for accessing Neolen's services.